4.5 Editorial Material

Cardiac PDEs and crosstalk between cAMP and cGMP signalling pathways in the regulation of contractility

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

Effect of Phosphodiesterase-5 Inhibition on Exercise Capacity and Clinical Status in Heart Failure With Preserved Ejection Fraction A Randomized Clinical Trial

Margaret M. Redfield et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)

Article Pharmacology & Pharmacy

Agents increasing cyclic GMP amplify 5-HT4-elicited positive inotropic response in failing rat cardiac ventricle

Faraz Afzal et al.

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2011)

Article Medicine, General & Internal

Effect of Nesiritide in Patients with Acute Decompensated Heart Failure

C. M. O'Connor et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Article Cardiac & Cardiovascular Systems

Natriuretic peptides increase β1-adrenoceptor signalling in failing hearts through phosphodiesterase 3 inhibition

Eirik Qvigstad et al.

CARDIOVASCULAR RESEARCH (2010)

Article Multidisciplinary Sciences

β2-Adrenergic Receptor Redistribution in Heart Failure Changes cAMP Compartmentation

Viacheslav O. Nikolaev et al.

SCIENCE (2010)

Article Cardiac & Cardiovascular Systems

Effect of piboserod, a 5-HT4 serotonin receptor antagonist, on left ventricular function in patients with symptomatic heart failure

John K. Kjekshus et al.

EUROPEAN JOURNAL OF HEART FAILURE (2009)

Article Pharmacology & Pharmacy

Effects of treatment with a 5-HT4 receptor antagonist in heart failure

J. A. K. Birkeland et al.

BRITISH JOURNAL OF PHARMACOLOGY (2007)

Review Pharmacology & Pharmacy

5-Hydroxytryptamine receptors in the human cardiovascular system

Alberto J. Kaumann et al.

PHARMACOLOGY & THERAPEUTICS (2006)

Review Medicine, General & Internal

Short-term risk of death after treatment with nesiritide for decompensated heart failure - A pooled analysis of randomized controlled trials

JD Sackner-Bernstein et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)

Article Cardiac & Cardiovascular Systems

Appearance of a ventricular 5-HT4 receptor-mediated inotropic response to serotonin in heart failure

E Qvigstad et al.

CARDIOVASCULAR RESEARCH (2005)

Article Biochemistry & Molecular Biology

Development of a selective peptide antagonist for the human natriuretic peptide receptor-B

J Deschênes et al.

PEPTIDES (2005)

Article Biochemistry & Molecular Biology

Novel single chain cAMP sensors for receptor-induced signal propagation

VO Nikolaev et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2004)

Article Pharmacology & Pharmacy

Functional serotonin 5-HT4 receptors in porcine and human ventricular myocardium with increased 5-HT4 mRNA in heart failure

T Brattelid et al.

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2004)

Review Cardiac & Cardiovascular Systems

What is the role of β-adrenergic signaling in heart failure?

MJ Lohse et al.

CIRCULATION RESEARCH (2003)

Article Cardiac & Cardiovascular Systems

α1-AR-induced positive inotropic response in heart is dependent on myosin light chain phosphorylation

GO Andersen et al.

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2002)

Article Medicine, General & Internal

Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure.

WS Colucci et al.

NEW ENGLAND JOURNAL OF MEDICINE (2000)

Article Cell Biology

A genetically encoded, fluorescent indicator for cyclic AMP in living cells

M Zaccolo et al.

NATURE CELL BIOLOGY (2000)